The latest coronavirus developments and scientific research on prevention and treatment.
The increased number of deceased donor liver transplants related to alcoholic hepatitis — up more than 50 percent over predicted numbers — was associated with rising alcohol sales…. read more.
According to ARRS’ American Journal of Roentgenology (AJR), radiologists need to be cognizant of the association between coronavirus disease (COVID-19) mRNA vaccination and myocarditis, as well as the role of… read more.
COVID-19 vaccination is about five times more effective at preventing COVID-related hospitalization than prior infection only, researchers reported on Oct. 29, 2021 in Morbidity and Mortality Weekly Report,… read more.
Patients enrolled in COVID Watch were 68 percent less likely to die from COVID-19. A retrospective cohort analysis found that an algorithm-based automated text messaging system saved a… read more.
The haze that blurs a blue sky or a beautiful skyline is caused by tiny particles called PM2.5. PM2.5 describes particulate matter, often made from pollution, less than 2.5… read more.
Does natural infection or vaccination prompt the body to generate more protective antibodies? It’s a question that researchers have been working on since the introduction of the first… read more.
Research has demonstrated the feasibility of mass producing customised respiratory protection for healthcare workers with a comfortable close-fitting seal, that is suitable for nearly 90% of face shapes and… read more.
Moderna, Inc. provided an update that the FDA has notified the Company that it will require additional time to complete its assessment of Moderna’s Emergency Use Authorization (EUA)… read more.
Pfizer Inc. and BioNTech SE announced that the FDA has authorized for emergency use the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age (also referred… read more.
-Moderna Inc. announced positive interim data from the Phase II/III study, called the KidCOVE study, of mRNA-1273 , the Company’s vaccine candidate against COVID-19, in children 6 to… read more.
Moderna, Inc. confirmed that the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended that the FDA grant an Emergency Use Authorization (EUA) for a booster dose… read more.
Pfizer Inc. and BioNTech SE announced that the FDA has authorized for emergency use a booster dose of the Pfizer-BioNTech COVID-19 Vaccine for individuals 65 years of age… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
